Specifically, we proposed to use TIN/NPI to ensure that each ASM participant has met the episode volume criteria for the EBCMs and for assigning clinicians to mandatory geographic areas described later in this section of this final rule
These findings suggest that ACOs transitioning to or remaining in two-sided model levels of the BASIC track outperform ACOs remaining in one-sided models of the BASIC track, and we refer commenters to discussion in the Regulatory Impact Analysis of this final rule for a more detailed explanation of the analysis underlying these findings
This is because overseas manufacturers and suppliers operate outside Australian jurisdiction, and therefore cannot be compelled to comply with the Therapeutic Goods Act 1989 (Cth) or any other Australian therapeutic goods legislation. New regulations in New Zealand In May 2026, the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) issued a formal consumer advisory warning New Zealanders against purchasing or using unapproved synthetic peptides and Selective Androgen Receptor Modulators (SARMs) promoted online
It is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, or any form of personal use
The synergy of BPC, KPV and PEA, offers a comprehensive approach often used to support inflammation, gut health, and conditions such as Inflammatory Bowel Disease (IBD)
Home-based therapy for autism is any structured therapeutic support that is delivered primarily in the home
.png)
